Literature DB >> 16884489

Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease.

F Raynaud1, A Marcilhac.   

Abstract

Apoptotic neuronal cell death is the cardinal feature of aging and neurodegenerative diseases, but its mechanisms remain obscure. Caspases, members of the cysteine protease family, are known to be critical effectors in central nervous system cellular apoptosis. More recently, the calcium-dependent proteases, calpains, have been implicated in cellular apoptotic processes. Indeed, several members of the Bcl-2 family of cell death regulators, nuclear transcription factors (p53) and caspases themselves are processed by calpains. Progressive regional loss of neurons underlies the irreversible pathogenesis of various neurodegenerative diseases such as Alzheimer's disease in adult brain. Alzheimer's disease is characterized by extracellular plaques of amyloid-beta peptide aggregates and intracellular neurofibrillary tangles composed of hyperphosphorylated tau leading to apoptotic cell death. In this review, we summarize the arguments showing that calpains modulate processes that govern the function and metabolism of these two key proteins in the pathogenesis of Alzheimer's disease. To conclude, this article reviews our understanding of calpain-dependent apoptotic neuronal cell death and the ability of these proteases to regulate intracellular signaling pathways leading to chronic neurodegenerative disorders such as Alzheimer's disease. Further research on these calpain-dependent mechanisms which promote or prevent cell apoptosis should help us to develop new approaches for preventing and treating neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884489     DOI: 10.1111/j.1742-4658.2006.05352.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  32 in total

1.  Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons.

Authors:  Janis Noonan; Riffat Tanveer; Allan Klompas; Aoife Gowran; Joanne McKiernan; Veronica A Campbell
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.

Authors:  Joao P Lopes; Catarina R Oliveira; Paula Agostinho
Journal:  Cell Mol Neurobiol       Date:  2007-10-27       Impact factor: 5.046

3.  Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration.

Authors:  Nikita Rudinskiy; Yulia Grishchuk; Anne Vaslin; Julien Puyal; André Delacourte; Harald Hirling; Peter G H Clarke; Ruth Luthi-Carter
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

Review 4.  Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology.

Authors:  Timothy J Revett; Glen B Baker; Jack Jhamandas; Satyabrata Kar
Journal:  J Psychiatry Neurosci       Date:  2013-01       Impact factor: 6.186

5.  Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.

Authors:  Natalia Louneva; Julia W Cohen; Li-Ying Han; Konrad Talbot; Robert S Wilson; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

6.  Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.

Authors:  Xiao-Xin Yan; Andreas Jeromin; A Jeromin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-06

7.  OGG1 is degraded by calpain following oxidative stress and cisplatin exposure.

Authors:  Jeff W Hill; Jennifer J Hu; Michele K Evans
Journal:  DNA Repair (Amst)       Date:  2008-02-21

Review 8.  Post-translational regulation of L-glutamic acid decarboxylase in the brain.

Authors:  Jianning Wei; Jang-Yen Wu
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

Review 9.  Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities.

Authors:  Venkata Prasuja Nakka; Anchal Gusain; Suresh L Mehta; Ram Raghubir
Journal:  Mol Neurobiol       Date:  2007-12-08       Impact factor: 5.590

10.  ALLN rescues an in vitro excitatory synaptic transmission deficit in Lis1 mutant mice.

Authors:  Joy Y Sebe; Marina Bershteyn; Shinji Hirotsune; Anthony Wynshaw-Boris; Scott C Baraban
Journal:  J Neurophysiol       Date:  2012-10-24       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.